The natural killer cell receptor specific for HLA-A allotypes: a novel member of the p58/p70 family of inhibitory receptors that is characterized by three immunoglobulin-like domains and is expressed as a 140-kD disulphide-linked dimer
about
NKp44, a triggering receptor involved in tumor cell lysis by activated human natural killer cells, is a novel member of the immunoglobulin superfamilyIdentification and molecular cloning of p75/AIRM1, a novel member of the sialoadhesin family that functions as an inhibitory receptor in human natural killer cellsMolecular cloning of NKp46: a novel member of the immunoglobulin superfamily involved in triggering of natural cytotoxicityPolymorphism and domain variability of human killer cell inhibitory receptorsIdentification and molecular characterization of NKp30, a novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cellsKIR2DS4 is a product of gene conversion with KIR3DL2 that introduced specificity for HLA-A * 11 while diminishing avidity for HLA-CActivating killer cell immunoglobulin-like receptor 2DS2 binds to HLA-A*11Identification of seventeen novel KIR variants: fourteen of them from two non-Caucasian donorsFunctional and molecular characterization of a KIR3DL2/p140 expressing tumor-specific cytotoxic T lymphocyte clone infiltrating a human lung carcinomaHLA-F and MHC class I open conformers are ligands for NK cell Ig-like receptorsDifferential expression of cytotoxic molecules and killer cell inhibitory receptors in CD8+ and CD56+ cutaneous lymphomasImmunogenetics as a tool in anthropological studiesCoevolution of killer cell Ig-like receptors with HLA-C to become the major variable regulators of human NK cellsMeiotic recombination generates rich diversity in NK cell receptor genes, alleles, and haplotypesDifferential binding to HLA-C of p50-activating and p58-inhibitory natural killer cell receptorsAssociation of HLA-B*51:01 with papillary thyroid carcinoma in the Chinese Han population of the Shandong coastal areas.Natural killer cells and cancer: regulation by the killer cell Ig-like receptors (KIR).HLA-Bw4-I-80 Isoform Differentially Influences Clinical Outcome As Compared to HLA-Bw4-T-80 and HLA-A-Bw4 Isoforms in Rituximab or Dinutuximab-Based Cancer ImmunotherapyChimpanzees use more varied receptors and ligands than humans for inhibitory killer cell Ig-like receptor recognition of the MHC-C1 and MHC-C2 epitopesDistribution of HLA-A, -B, and -C alleles and HLA/KIR combinations in Han population in China.Killer cell immunoglobulin-like receptors in HLA-B27-associated acute anterior uveitis, with and without axial spondyloarthropathyKIR polymorphisms modulate peptide-dependent binding to an MHC class I ligand with a Bw6 motifCobalt-mediated dimerization of the human natural killer cell inhibitory receptor.Identification and molecular characterization of a natural mutant of the p50.2/KIR2DS2 activating NK receptor that fails to mediate NK cell triggering.Association of activating KIR copy number variation of NK cells with containment of SIV replication in rhesus monkeys.Recombinant structures expand and contract inter and intragenic diversification at the KIR locusIdentification of cell surface molecules characterizing human cutaneous T-cell lymphomas.KIR/HLA interactions and pathogen immunityInfluence of interleukin IL-2 and IL-12 + IL-18 on surface expression of immunoglobulin-like receptors KIR2DL1, KIR2DL2, and KIR3DL2 in natural killer cellsConjunctival scarring in trachoma is associated with the HLA-C ligand of KIR and is exacerbated by heterozygosity at KIR2DL2/KIR2DL3.HLA class I-specific inhibitory receptors in human T lymphocytes: interleukin 15-induced expression of CD94/NKG2A in superantigen- or alloantigen-activated CD8+ T cells.HIV modulates the expression of ligands important in triggering natural killer cell cytotoxic responses on infected primary T-cell blastsKIR and HLA Genotypes Implicated in Reduced Killer Lymphocytes Immunity Are Associated with Vogt-Koyanagi-Harada Disease.Self and viral peptides can initiate lysis by autologous natural killer cellsMutation at positively selected positions in the binding site for HLA-C shows that KIR2DL1 is a more refined but less adaptable NK cell receptor than KIR2DL3.Roles for HLA and KIR polymorphisms in natural killer cell repertoire selection and modulation of effector function.Inhibitory receptors sensing HLA-G1 molecules in pregnancy: decidua-associated natural killer cells express LIR-1 and CD94/NKG2A and acquire p49, an HLA-G1-specific receptorThe D0 domain of KIR3D acts as a major histocompatibility complex class I binding enhancer.Putting the natural killer cell in its place.Short KIR haplotypes in pygmy chimpanzee (Bonobo) resemble the conserved framework of diverse human KIR haplotypes
P2860
Q22008826-BAC6060D-E229-4D3E-80B0-4B8178DAC755Q22010576-7EDB3919-CE15-461C-B7C7-2E46C4268150Q24310824-9B1D58A7-5D0A-4B5A-9415-3D241A3A7E72Q24329103-A6057632-C29E-446D-9494-255AF6824DC6Q24671834-C4422039-8B83-4BB9-8D00-89790B4FA31CQ27657994-55B264AC-77AD-40E7-BD9D-947789BBE1DEQ27681802-E48B1593-C4F1-469A-9AAE-933F6F7A5609Q28199747-890B0787-5F36-4F51-AD49-C29C51A00CECQ28210382-DC6456F4-38DC-4C4E-9D57-F550649914CDQ28298119-33CDA975-FF3C-4DE0-BA0D-BC855BECF85FQ28364322-C482A322-7F4F-4AE0-A443-86FFE538EFFFQ28740417-AD95E2FB-A23D-44B2-8A84-D65E38A36AD0Q28743223-29A31B4F-B758-496A-A7EB-5412B3386F23Q28754594-565BD929-99AC-4CAD-B4F7-75128638549CQ28776435-487AA0EC-EACE-46D8-92C8-F909D16D2A09Q33632666-D2CBFF69-901D-435B-B9E0-D82F86418A6CQ33672480-1497644F-CD4D-4154-8C63-90F280B163C6Q33785744-B62544B1-45F8-4D11-95CE-5C94D293C9BCQ33789518-9989314C-01A7-4CB7-9168-C12394D564BDQ33796633-CCBF0517-8142-4D1E-9F58-28A0E091A94EQ33845247-CAFACB31-F06F-4291-9069-DA90DFE58154Q33851496-AE31C378-66D2-40AB-A4B5-CF4B38ADDCDFQ33902254-A0D650E1-A71C-40EF-871C-1D6D55B068EAQ33932618-298CC615-3655-48F9-A80E-31361F6A66C2Q34109760-13E4347B-73D7-4B49-827A-70CC52A50069Q34581495-F73C7C67-EE53-474E-9609-111ED6FE9A1FQ34769861-628664DA-046B-4C02-B39F-2B6B6A0370E7Q35001169-94DA300E-7530-4E0C-9C8C-14AA90A75060Q35104217-BB98BA97-E13E-41D8-B1B6-C00B8DE6F011Q35126671-FF16B429-0211-42BF-A8A4-BA39BDD5DBBBQ35798486-D631204E-56D1-4D03-B508-7B9BB8B49C55Q35925041-D79D8BA6-1692-4950-BF25-652ED02F70D2Q36094774-754ABC7B-5AE6-4902-87E4-4DC589C0F3DAQ36140540-4CF4E808-7549-400B-A9A0-F34633888C4CQ36227213-D0CB19F0-9DD9-450A-AF7A-05724D9B05BBQ36228467-13646E30-732E-413D-9252-3B4D1D10BCDCQ36364483-19DE98D4-520E-4583-87E2-79FF94DC0E9CQ36371178-9EA33FDD-6B66-4B0C-830C-D10410B973EBQ36372539-FA32BBF0-B82E-4763-8C05-A77BD90EF74CQ36376124-AF7D7191-3DCA-4417-A6C4-51662C239A4C
P2860
The natural killer cell receptor specific for HLA-A allotypes: a novel member of the p58/p70 family of inhibitory receptors that is characterized by three immunoglobulin-like domains and is expressed as a 140-kD disulphide-linked dimer
description
1996 nî lūn-bûn
@nan
1996 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
The natural killer cell recept ...... 140-kD disulphide-linked dimer
@ast
The natural killer cell recept ...... 140-kD disulphide-linked dimer
@en
The natural killer cell recept ...... 140-kD disulphide-linked dimer
@nl
type
label
The natural killer cell recept ...... 140-kD disulphide-linked dimer
@ast
The natural killer cell recept ...... 140-kD disulphide-linked dimer
@en
The natural killer cell recept ...... 140-kD disulphide-linked dimer
@nl
prefLabel
The natural killer cell recept ...... 140-kD disulphide-linked dimer
@ast
The natural killer cell recept ...... 140-kD disulphide-linked dimer
@en
The natural killer cell recept ...... 140-kD disulphide-linked dimer
@nl
P2093
P2860
P3181
P356
P1476
The natural killer cell recept ...... 140-kD disulphide-linked dimer
@en
P2093
C di Donato
S Verdiani
P2860
P304
P3181
P356
10.1084/JEM.184.2.505
P407
P577
1996-08-01T00:00:00Z